Period of time： 2014年1期
Publisher： Informa Healthcare
Founded in： 2002
Total resources： 54
ISSN： 1474-0338
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 4,issue 1
Menu
Immune function testing of human pharmaceuticals: regulatory overshoot?
By van der Laan Jan Willem,van Loveren Henk in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.
Access to resources
Recommend
Drug interactions with angiotensin receptor blockers
By Böhler Steffen,Pittrow David,Bramlage Peter,Kirch Wilhelm in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.By Dettmeyer Reinhard B,Preuß Johanna,Wollersen Heike,Madea Burkhard in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Cardiovascular complications of immunosuppressive agents in renal transplant recipients
By Olyaei Ali J,deMattos Angelo M,Bennett William M in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Toxicity of the topoisomerase I inhibitors
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?
By Ananth Jambur,Kolli Smita in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Tolcapone in Parkinson’s disease: liver toxicity and clinical efficacy
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects
By Harwood Paul J,Giannoudis Peter V in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Drug-induced movement disorders in children and adolescents
By Rodnitzky Robert L in (2005)
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.Mechanistic basis of adverse drugreactions: the perils of inappropriate dose schedules
Expert Opinion on Drug Safety,volume 4,issue 1 , Vol. 4, Iss. 1, 2005-01 , pp.
Previous
Next